Clinical Trials Directory

Trials / Completed

CompletedNCT04030312

Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant

Effectiveness of Donor Human Milk Supplementation Compared to Infant Formula for the Treatment of Hypoglycemia in the Breastfed Infant in the Normal Newborn Nursery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
University of Nebraska · Academic / Other
Sex
All
Age
1 Minute – 72 Hours
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare if newborn infant hypoglycemia can be improved with bottle supplementation of commercially-sterilized donor human milk compared to standard infant formula. Hypothesis is that supplementation with commercially-sterilized donor human milk will improve hypoglycemia and limit formula use in exclusively breastfed infants.

Detailed description

Enrolled infant participants will receive a maximum of two bottle feeding supplementations (of their designated treatment arm for either 20 calorie-per-ounce commercially-sterilized donor human milk OR 20-calorie-per-ounce standard infant formula) as treatment if they meet hypoglycemia criteria. Infant participants will complete the study if 1) they have received two bottle feeding supplementations for treatment of hypoglycemia, 2) they only received one bottle supplementation and hypoglycemia resolved, 3) if the medical teams deems the infants requires a higher level of care for their hypoglycemia (example: admission to the newborn intensive care unit for intravenous fluids with dextrose).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBottle Supplementation--Commercially-Sterilized Donor Human MilkSupplementation by bottle with 20-calorie-per-ounce commercially-sterilized donor human milk (up to 15 ml, up to two times) for infants meeting hypoglycemia criteria and randomized to this treatment arm.
DIETARY_SUPPLEMENTBottle Supplementation--Standard Infant FormulaSupplementation by bottle with 20-calorie-per-ounce standard infant formula (up to 15 ml, up to two times) for infants meeting hypoglycemia criteria and randomized to this treatment arm.

Timeline

Start date
2020-05-01
Primary completion
2022-07-01
Completion
2023-04-10
First posted
2019-07-23
Last updated
2023-09-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04030312. Inclusion in this directory is not an endorsement.